CClinicalTrials.gg
CompletedNCT00935896NormallungUpdated Jul 9, 2009

High Tidal Volume Induces Inflammation In Normal Lungs

An interventional study of Low tidal volume and Low tidal volume in Mechanically Ventilated Patients and Normal Lungs, sponsored by Federal University of Rio Grande do Sul. Completed at 2 sites in Brazil. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2009-07-09.

Sponsored by Federal University of Rio Grande do Sul · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

Objective: To compare the effects of a protective versus a conventional ventilatory strategy, on systemic and in lung production of tumor necrosis factor-alpha (TNF-alpha) and interleukin-8 (IL-8) in patients without lung disease.

Hypothesis: High tidal volumes induce inflammation in patients without lung disease Design: Prospective control-randomized study. Patients and Setting: Twenty patients without lung disease and submitted to mechanical ventilation admitted to one trauma and one general adult intensive care unit of two different university hospitals.

Interventions: Patients were randomized to receive mechanical ventilation either with tidal volume (VT) of 10-12 ml/kg predicted body weight (high VT group) or with VT of 5-7 ml/kg predicted body weight (low VT group) with an O2 inspiratory fraction (FIO2) enough to keep arterial oxygen saturation > 90% with positive end-expiratory pressure (PEEP) of 5 cmH2O during 12 hours after admission to the study.

02

Conditions studied

  • Mechanically Ventilated Patients
  • Normal Lungs

Browse trials for

Keywords

  • Ventilator-associated lung injury
  • Tumor necrosis factor-alpha
  • Interleukin-8
  • Mechanical ventilation
  • Low tidal volume ventilation
  • Normal lungs
03

In context

Inflammation

3,438 studies on the registry are indexed under Inflammation; 629 are open to participants now.

This study's planned enrollment of 20 is below the median of 50 across 2,436 interventional studies indexed under Inflammation.

Browse Inflammation studies →

Lead sponsor

Federal University of Rio Grande do Sul is the lead sponsor of 118 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. age ≥ 16 years;
  2. anticipated survival > 24 hours;
  3. need for mechanical ventilation for at least 12 hours and
  4. hemodynamic stability (MAP>65 mmHg, HR\<100 beats/min, diuresis > 1 ml/kg/h, no catecholamine requirement or fluid challenge).

Exclusion criteria

Exclusion Criteria:

  1. history of any lung disease, use of immunosuppressive medication, recent infections, previous thromboembolic disease, recent ventilatory support, and participation in another clinical trial. Absence of lung disease was defined by the following clinical criteria: (a) no evidence of respiratory infection (white blood cell count \<10x103/µl, temperature > 380C, purulent sputum), (b) normal chest roentgenogram, (c) PaO2/FIO2 ratio > 300, (d) and a normal clinical respiratory history.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • No intervention
    high VT group
  • Experimental
    Low tidal volume

    Procedure: Low tidal volume · Other: low tidal volume

Interventions

  • ProcedureLow tidal volume

    twenty patients were randomly (opaque sealed envelopes) assigned to receive mechanical ventilation in volume-controlled mode either with VT of 10-12 ml/kg predicted body weight (high VT group, n=10) or with VT of 5-7 ml/kg predicted body weight (low VT group, n=10) with an inspiratory fraction of oxygen (FIO2) set at the minimal level at which an arterial oxygen saturation of \> 90% and minimal PEEP (4-5cmH2O). The predicted body weight of male patients was calculated as equal to 50+0.91(centimeters of height-152.4); that of female patients was calculated as equal to 45.5+0.91(centimeters of height-152.4).

  • ProcedureLow tidal volume

    Immediately after ICU admission, once all inclusion and exclusion criteria were met and consent obtained, twenty patients (16 men, 4 women, median age of 49 yrs) were randomly (opaque sealed envelopes) assigned to receive mechanical ventilation in volume-controlled mode either with VT of 10-12 ml/kg predicted body weight (high VT group, n=10) or with VT of 5-7 ml/kg predicted body weight (low VT group, n=10) with an inspiratory fraction of oxygen (FIO2) set at the minimal level at which an arterial oxygen saturation of \> 90% and minimal PEEP (4-5cmH2O). The predicted body weight of male patients was calculated as equal to 50+0.91(centimeters of height-152.4); that of female patients was calculated as equal to 45.5+0.91(centimeters of height-152.4)

  • Otherlow tidal volume

    tidal volume of 5-7 ml/kg predicted body weight

06

What researchers measure

Primary outcomes

  1. Lung cytokines in mechanically ventilated patients

    Time frame: 30 months

07

Study locations

2 sites
  • Complexo Hospitalar Santa Casa
    Porto Alegre, RS 900000, Brazil
  • Hospital de Pronto Socorro
    Porto Alegre, RS 90000, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00935896
Lead sponsor
Federal University of Rio Grande do Sul
Collaborators
Programa de Pós-Graduação em Clínica Médica, Faculdade de Medicina
First posted
Jul 9, 2009
Last update
Jul 9, 2009

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion